{"id":51470,"date":"2022-12-01T18:02:05","date_gmt":"2022-12-01T17:02:05","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/"},"modified":"2022-12-01T18:02:05","modified_gmt":"2022-12-01T17:02:05","slug":"global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/","title":{"rendered":"Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5675616\/liquid-biopsy-markets-by-cancer-usage?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=dwf22s&amp;utm_campaign=1783208+-+Global+Liquid+Biopsy+Market+Report+to+2027%3A+Featuring+Abbott+Laboratories%2C+AccuraGen%2C+BGI+Genomics+and+Biocartis+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, &amp; Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20221201005819\/en\/1652888\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20221201005819\/en\/1652888\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Potential are all explored in this report. What is the impact of the COVID pandemic on the Liquid Biopsy market? The publisher looks at Price and Volume Outlooks by type of cancer.\n<\/p>\n<p>\nThis report provides detailed analysis. Circulating Tumor Cells? Cell Free DNA? Exosomes? Find out about the technology in readily understood terms that explain the jargon. Find the opportunities and the pitfalls. Understand growth expectations and the ultimate potential market size.\n<\/p>\n<p>\nA revolution in cancer diagnostics is occurring using in vitro blood testing to identify cancer DNA. The technology has created the possibility of widespread screening for all types of cancers with a blood test.\n<\/p>\n<p>\nIllumina is now working on the Circulating Cell-Free Genome Atlas (CCGA) to help identify cancer early. The technology is moving faster than the market. New technology that definitively identifies disease conditions from blood samples is poised to replace expensive invasive surgical biopsy procedures. The market is still in its infancy but has just moved out of the development phase and into the growth phase.\n<\/p>\n<p>\nThe impact on the health care industry is enormous. The report forecasts the market size looking out 5 years. In addition, the report looks at potential market sizes by country, by cancer and by the four types of usage: screening, diagnosis, therapy selection and recurrence monitoring.\n<\/p>\n<p>\nUse independent research that makes you the expert. Your credit card order sends the report to your inbox instantly. Check all your licensing options but don&#8217;t worry, your order is available as a credit if you wish to upgrade to more information. Get an extra player on your team as unlimited assistance and breakout data is included with your purchase.\n<\/p>\n<p>\nThe report includes detailed breakouts for 15 Countries and 4 Regions along with breakouts for Lung, Breast, Colorectal, Prostate, Cervical, and Other Cancers as well as breakouts by Screening\/Early Detection, Diagnostic, Therapy Monitoring and Recurrence Monitoring.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nAbbott Laboratories\n<\/li>\n<li>\nAccuraGen Inc.\n<\/li>\n<li>\nAcuamark Diagnostics\n<\/li>\n<li>\nAdmera Health, LLC\n<\/li>\n<li>\nAgilent\/Dako\n<\/li>\n<li>\nAmoy Diagnostics Co., Ltd\n<\/li>\n<li>\nAnchor Dx\n<\/li>\n<li>\nANGLE plc\n<\/li>\n<li>\nApplied DNA Sciences\n<\/li>\n<li>\nARUP Laboratories\n<\/li>\n<li>\nAVIVA Systems Biology\n<\/li>\n<li>\nBaylor Miraca Genetics Laboratories\n<\/li>\n<li>\nBeckman Coulter Diagnostics\n<\/li>\n<li>\nBecton, Dickinson and Company\n<\/li>\n<li>\nBGI Genomics Co. Ltd\n<\/li>\n<li>\nBioarray Genetics\n<\/li>\n<li>\nBiocartis\n<\/li>\n<li>\nBiocept, Inc.\n<\/li>\n<li>\nBiodesix Inc.\n<\/li>\n<li>\nBioFluidica\n<\/li>\n<li>\nbioMerieux Diagnostics\n<\/li>\n<li>\nBioneer Corporation\n<\/li>\n<li>\nBio-Rad Laboratories, Inc\n<\/li>\n<li>\nBio-Techne\n<\/li>\n<li>\nBioview\n<\/li>\n<li>\nBolidics\n<\/li>\n<li>\nBoreal Genomics\n<\/li>\n<li>\nBurning Rock\n<\/li>\n<li>\nCardiff Oncology\n<\/li>\n<li>\nCaris Molecular Diagnostics\n<\/li>\n<li>\nCellCarta\n<\/li>\n<li>\nCellMax Life\n<\/li>\n<li>\nCepheid (Danaher)\n<\/li>\n<li>\nCirculogene\n<\/li>\n<li>\nCizzle Biotech\n<\/li>\n<li>\nClinical Genomics\n<\/li>\n<li>\nCytolumina Technologies Corp\n<\/li>\n<li>\nDatar Cancer Genetics Limited\n<\/li>\n<li>\nDiagnologix LLC\n<\/li>\n<li>\nDxcover\n<\/li>\n<li>\nEnzo Biochem\n<\/li>\n<li>\nAnd Many More Companies!\n<\/li>\n<\/ul>\n<p>\n<strong>Key Topics Covered:<\/strong>\n<\/p>\n<p>\n<strong>1 Market Guides<\/strong>\n<\/p>\n<p>\n<strong>2 Introduction and Market Definition<\/strong>\n<\/p>\n<p>\n<strong>3 Market Overview<\/strong>\n<\/p>\n<p>\n<strong>4 Market Trends<\/strong>\n<\/p>\n<p>\n4.1 Factors Driving Growth\n<\/p>\n<p>\n4.1.1 Non-Invasive Game Changer\n<\/p>\n<p>\n4.1.2 Lower Cost\n<\/p>\n<p>\n4.1.3 Greater Accuracy\n<\/p>\n<p>\n4.1.4 Wide Range of Potential Uses\n<\/p>\n<p>\n4.1.5 Aging Population\n<\/p>\n<p>\n4.2 Factors Limiting Growth\n<\/p>\n<p>\n4.2.1 Lower prices\n<\/p>\n<p>\n4.2.2 Lack of Standards\n<\/p>\n<p>\n4.2.3 Protocol Resistance\n<\/p>\n<p>\n4.2.4 Initial Adoption Cost\n<\/p>\n<p>\n4.2.5 Conclusion\n<\/p>\n<p>\n4.3 Instrumentation and Automation\n<\/p>\n<p>\n4.3.1 Instruments Key to Market Share\n<\/p>\n<p>\n4.3.2 Bioinformatics Plays a Role\n<\/p>\n<p>\n4.4 Diagnostic Technology Development\n<\/p>\n<p>\n4.4.1 Next Generation Sequencing Fuels a Revolution\n<\/p>\n<p>\n4.4.2 Impact of NGS on pricing\n<\/p>\n<p>\n4.4.3 Pharmacogenomics Blurs Diagnosis and Treatment\n<\/p>\n<p>\n4.4.4 CGES Testing, A Brave New World\n<\/p>\n<p>\n4.4.5 Biochips\/Giant magneto resistance based assay\n<\/p>\n<p>\n<strong>5 Liquid Biopsy Recent Developments<\/strong>\n<\/p>\n<p>\n<strong>6 Profiles of Key Players<\/strong>\n<\/p>\n<p>\n<strong>7 The Global Market for Liquid Biopsy Diagnostics<\/strong>\n<\/p>\n<p>\n<strong>8 Global Liquid Biopsy Diagnostic Markets &#8211; By Cancer<\/strong>\n<\/p>\n<p>\n<strong>9 Global Liquid Biopsy Diagnostic Markets &#8211; by Usage<\/strong>\n<\/p>\n<p>\n<strong>10 Global Liquid Biopsy Diagnostic Markets &#8211; by Place<\/strong>\n<\/p>\n<p>\n<strong>11 Global Liquid Biopsy Diagnostic Markets &#8211; by Marker<\/strong>\n<\/p>\n<p>\n<strong>12 Global Liquid Biopsy Diagnostic Markets &#8211; by Product<\/strong>\n<\/p>\n<p>\n<strong>13 Appendices<\/strong>\n<\/p>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5675616\/liquid-biopsy-markets-by-cancer-usage?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=dwf22s&amp;utm_campaign=1783208+-+Global+Liquid+Biopsy+Market+Report+to+2027%3A+Featuring+Abbott+Laboratories%2C+AccuraGen%2C+BGI+Genomics+and+Biocartis+Among+Others&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/pgwet7<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#x6d;&#x61;&#x69;&#x6c;&#x74;&#x6f;&#x3a;&#x70;&#x72;&#x65;&#x73;&#x73;&#x40;&#x72;&#101;&#115;&#101;&#97;&#114;&#99;&#104;&#97;&#110;&#100;&#109;arkets&#46;c&#x6f;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">press&#64;&#114;&#101;&#115;&#101;&#97;&#114;&#99;&#x68;&#x61;&#x6e;&#x64;&#x6d;&#x61;&#x72;&#x6b;&#x65;&#x74;&#x73;&#x2e;com<\/a><\/p>\n<p>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, &amp; Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Potential are all explored in this report. What is the &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-51470","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.5 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, &amp; Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Potential are all explored in this report. What is the ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2022-12-01T17:02:05+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20221201005819\/en\/1652888\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2022-12-01T17:02:05+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/\"},\"wordCount\":671,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221201005819\\\/en\\\/1652888\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/\",\"name\":\"Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221201005819\\\/en\\\/1652888\\\/21\\\/logo.jpg\",\"datePublished\":\"2022-12-01T17:02:05+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221201005819\\\/en\\\/1652888\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20221201005819\\\/en\\\/1652888\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Liquid Biopsy Markets by Cancer, Usage, Biomarker, Place, &amp; Product With Price and Volume Outlook. Including Executive and Consultant Guides and Customized Forecasting and Analysis 2023-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The Screening, Diagnostic, Therapy Selection, Recurrence Monitoring and Screening Market Potential are all explored in this report. What is the ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2022-12-01T17:02:05+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20221201005819\/en\/1652888\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others &#8211; ResearchAndMarkets.com","datePublished":"2022-12-01T17:02:05+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/"},"wordCount":671,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221201005819\/en\/1652888\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/","name":"Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20221201005819\/en\/1652888\/21\/logo.jpg","datePublished":"2022-12-01T17:02:05+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20221201005819\/en\/1652888\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20221201005819\/en\/1652888\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-liquid-biopsy-market-report-to-2027-featuring-abbott-laboratories-accuragen-bgi-genomics-and-biocartis-among-others-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Liquid Biopsy Market Report to 2027: Featuring Abbott Laboratories, AccuraGen, BGI Genomics and Biocartis Among Others &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51470","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=51470"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/51470\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=51470"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=51470"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=51470"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}